Virtual reality exposure therapy for anxiety and related disorders: A meta-analysis of randomized controlled trials
| Autor: | Gordon J.G. Asmundson, Paul M. G. Emmelkamp, Per Carlbring, Emily Carl, Andrew Levihn-Coon, Mark B. Powers, Aliza T. Stein, Barbara O. Rothbaum, Jamie R. Pogue |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
VR
050103 clinical psychology Implosive Therapy Anxiety Placebo Virtual reality VRET law.invention Stress Disorders Post-Traumatic Virtual Reality Exposure Therapy 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law medicine Humans 0501 psychology and cognitive sciences Agoraphobia Randomized Controlled Trials as Topic Panic disorder 05 social sciences Social anxiety Phobia Social medicine.disease Anxiety Disorders 030227 psychiatry Psychiatry and Mental health Clinical Psychology Phobic Disorders Sample Size Meta-analysis Panic Disorder medicine.symptom Psychology Meta-Analysis Clinical psychology |
| Zdroj: | Carl, E, Stein, A T, Levihn-Coon, A, Pogue, J R, Rothbaum, B, Emmelkamp, P, Asmundson, G J G, Carlbring, P & Powers, M B 2019, ' Virtual reality exposure therapy for anxiety and related disorders : A meta-analysis of randomized controlled trials ', Journal of Anxiety Disorders, vol. 61, pp. 27-36 . https://doi.org/10.1016/j.janxdis.2018.08.003 |
| ISSN: | 0887-6185 |
| Popis: | Trials of virtual reality exposure therapy (VRET) for anxiety-related disorders have proliferated in number and diversity since our previous meta-analysis that examined 13 total trials, most of which were for specific phobias (Powers & Emmelkamp, 2008). Since then, new trials have compared VRET to more diverse anxiety and related disorders including social anxiety disorder (SAD), posttraumatic stress disorder (PTSD), and panic disorder (PD) with and without agoraphobia. With the availability of this data, it is imperative to re-examine the efficacy of VRET for anxiety. A literature search for randomized controlled trials of VRET versus control or in vivo exposure yielded 30 studies with 1057 participants. Fourteen studies tested VRET for specific phobias, 8 for SAD or performance anxiety, 5 for PTSD, and 3 for PD. A random effects analysis estimated a large effect size for VRET versus waitlist (g = 0.90) and a medium to large effect size for VRET versus psychological placebo conditions (g = 0.78). A comparison of VRET and in vivo conditions did not show significantly different effect sizes (g = -0.07). These findings were relatively consistent across disorders. A meta-regression analysis revealed that larger sample sizes were associated with lower effect sizes in VRET versus control comparisons (β = -0.007, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect